14-day Premium Trial Subscription Sign Up For FreeGet Free

DENTSPLY International Inc. Stock Forecast NASDAQ:XRAY

Price Target and Analyst Ratings

Most Recent Rating

On August 09, 2021 "HC Wainwright" gave "$72.00 - $66.00" rating for XRAY. The price target was set to $60.29+0.9%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-09 $72.00 - $66.00 Target Lowered by HC Wainwright $59.53 $60.29+0.9%
2021-08-06 $77.00 - $79.00 Target Raised by Barrington Research $60.29 $59.75→7.1%
2021-05-13 Neutral Target Raised by HC Wainwright $66.61 $60.00 → $72.00
2021-05-07 Outperform Target Raised by Barrington Research $68.47 $71.00 → $77.00
2021-05-07 Neutral Target Raised by HC Wainwright $68.47 $60.00 → $72.00
2021-05-07 Outperform Target Raised by Robert W. Baird $68.47 $71.00 → $78.00
2021-05-06 Overweight Target Raised by Piper Sandler $67.39 $70.00 → $75.00
2021-03-08 Market Perform - Outperform Upgraded by Barrington Research $61.90 $71.00
2021-03-02 Neutral Reiterated by HC Wainwright $59.27 $55.00 → $60.00
2021-03-02 Neutral Target Raised by HC Wainwright $59.27 $55.00 → $60.00
2021-03-02 Outperform Target Raised by Robert W. Baird $59.27 $62.00 → $71.00
2021-03-02 Market Perform - Outperform Upgraded by Barrington Research $59.27 $71.00
2021-03-02 Underweight Target Raised by Barclays $59.27 $50.00 → $55.00
2021-03-01 Overweight Target Raised by Piper Sandler $59.71 $63.00 → $70.00
2021-01-05 Neutral Target Raised by HC Wainwright $55.29 $49.00 → $55.00
2021-01-05 Outperform Target Raised by Robert W. Baird $55.29 $58.00 → $62.00
2021-01-05 Neutral Reiterated by HC Wainwright $55.29 $49.00 → $55.00
2021-01-05 Underweight Target Raised by Barclays $55.29 $40.00 → $44.00
2020-12-18 Buy - Hold Downgraded by Stifel Nicolaus $52.60 $52.00
2020-12-15 Overweight Target Raised by Piper Sandler $53.82 $51.00 → $61.00
2020-11-17 Equal Weight - Underweight Downgraded by Barclays $48.90 $40.00
2020-11-09 Neutral Target Raised by HC Wainwright $51.40 $45.00 → $49.00
2020-10-22 Neutral - Buy Upgraded by Guggenheim $48.34
2020-10-05 Neutral Target Raised by JPMorgan Chase & Co. $44.81 $45.00 → $47.00
2020-08-10 Neutral Target Lowered by HC Wainwright $45.40 $50.00 → $45.00
2020-07-20 Buy Target Raised by Bank of America $43.48 $54.00 → $56.00
2020-06-16 Overweight Initiated by Piper Sandler $45.18 $51.00
2020-06-15 Neutral Target Raised by HC Wainwright $43.89 $38.00 → $50.00
2020-05-27 In-Line - Outperform Upgraded by Evercore ISI $47.79 $50.00
2020-05-14 Hold Target Lowered by Cfra $37.88 $53.00 → $38.00
2020-05-11 Equal Weight Target Lowered by Barclays $40.31 $42.00 → $40.00
2020-05-11 Neutral Target Lowered by UBS Group $40.31 $59.00 → $44.00
2020-05-11 Outperform - Market Perform Downgraded by Barrington Research $40.31
2020-04-24 Neutral Target Lowered by HC Wainwright $39.31 $51.00 → $38.00
2020-04-19 Neutral - Outperform Upgraded by Robert W. Baird $40.86
2020-04-19 Buy Reiterated by Credit Suisse Group $40.86 $50.00
2020-04-08 Neutral - Outperform Upgraded by Robert W. Baird $39.58 $57.00 → $49.00
2020-04-07 Buy - Neutral Downgraded by Goldman Sachs Group $38.09 $58.00 → $40.00

XRAY Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -4.55% during the next 3 months and, with a 90% probability hold a price between $54.38 and $62.17 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $56.92 $61.00 $65.08
2021-09-21 $56.87 $60.95 $65.03
2021-09-22 $56.82 $60.90 $64.98
2021-09-23 $56.77 $60.85 $64.93
2021-09-24 $56.72 $60.80 $64.89
2021-09-27 $56.67 $60.75 $64.84
2021-09-28 $56.62 $60.70 $64.79
2021-09-29 $56.57 $60.66 $64.74
2021-09-30 $56.52 $60.61 $64.69
2021-10-01 $56.47 $60.56 $64.64
2021-10-04 $56.43 $60.51 $64.59
2021-10-05 $56.38 $60.46 $64.54
2021-10-06 $56.33 $60.41 $64.49
2021-10-07 $56.28 $60.36 $64.44
2021-10-08 $56.23 $60.31 $64.39
2021-10-11 $56.18 $60.26 $64.34
2021-10-12 $56.13 $60.21 $64.29
2021-10-13 $56.08 $60.16 $64.24
2021-10-14 $56.03 $60.11 $64.19
2021-10-15 $55.98 $60.06 $64.15
2021-10-18 $55.93 $60.01 $64.10
2021-10-19 $55.88 $59.96 $64.05
2021-10-20 $55.83 $59.92 $64.00
2021-10-21 $55.78 $59.87 $63.95
2021-10-22 $55.73 $59.82 $63.90
2021-10-25 $55.69 $59.77 $63.85
2021-10-26 $55.64 $59.72 $63.80
2021-10-27 $55.59 $59.67 $63.75
2021-10-28 $55.54 $59.62 $63.70
2021-10-29 $55.49 $59.57 $63.65

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT